Chronic Kidney Disease
Part of NephTimes
Proposed causes of eGFR difference did not account for its association with adverse outcomes in CKD.
A study examined patients at two Danish hospitals receiving a shared decision-making and dialysis choice intervention.
Real-world data provided strong evidence supporting GLP-1 RA use in patients with diabetes receiving dialysis.
A study shed light on the association between childhood cancer treatment and CKD or hypertension after treatment.
Researchers identified a combination biomarker panel to predict chronic kidney disease progression among children.
A population health management intervention for CKD lowered hospitalization rates but not costs.
An AI-based gout management system was associated with better serum urate and CKD outcomes in a recent study.
"Nudge" letters to patients and practices were not effective at increasing uptake of RASi or SGLT2i for CKD management.
Dietitian Jessica Strawn helps bust some common nutrition myths for patients with CKD.
A literature review showed a significant increase in hyperkalemia among patients with CKD despite treatment with RAASi.
Research revealed an association between social isolation and the onset of CVD and accelerated death in CKD.
A study found that primary care physician-nephrologist collaboration did not improve kidney or CV outcomes in stage 5 CKD.
Editorial board chair Dr. Ajay Singh discusses how GFR may vary between sexes and affect rates of CKD.
Elevated glucose uptake in adipose tissue of patients with gout may contribute to CKD progression.
Kidney Care Partners visited called on Congress to support policies benefitting Americans with kidney disease.
AstraZeneca and Aptar Digital Health are partnering on screening algorithms to detect CKD and other conditions.
Study results suggest that psychosocial interventions effectively reduce depression symptoms in people with CKD.
Variability in eGFR over time is associated with risks of cardiovascular and kidney outcomes and mortality in those with CKD.
An observational study shed light on how family medical history may affect chronic kidney disease (CKD) outcomes.
Fibrate use is associated with higher incidence of CKD but lower risk for ESKD and mortality, a study found.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.